Clinical trial
A Phase I Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers
NCT02587442 is registered in ClinicalTrials.gov with Original BioMedicals Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers
- Lead sponsor
- Original BioMedicals Co. Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- Not reported
- Enrollment
- 27 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.